These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 2431952)
1. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Fölsch UR; Cantor P; Wilms HM; Schafmayer A; Becker HD; Creutzfeldt W Gastroenterology; 1987 Feb; 92(2):449-58. PubMed ID: 2431952 [TBL] [Abstract][Full Text] [Related]
2. A cholecystokinin releasing peptide mediates feedback regulation of pancreatic secretion. Lu L; Louie D; Owyang C Am J Physiol; 1989 Feb; 256(2 Pt 1):G430-5. PubMed ID: 2465698 [TBL] [Abstract][Full Text] [Related]
3. Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice. Miyasaka K; Funakoshi A; Matsumoto M; Kitani K Dig Dis Sci; 1993 Apr; 38(4):674-9. PubMed ID: 8462366 [TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin mediates feedback regulation of pancreatic enzyme secretion in rats. Louie DS; May D; Miller P; Owyang C Am J Physiol; 1986 Feb; 250(2 Pt 1):G252-9. PubMed ID: 3953805 [TBL] [Abstract][Full Text] [Related]
5. Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats. Nakamura R; Miyasaka K; Funakoshi A; Kitani K Proc Soc Exp Biol Med; 1989 Nov; 192(2):182-6. PubMed ID: 2813449 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats. Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212 [TBL] [Abstract][Full Text] [Related]
7. Luminal bile regulates cholecystokinin release in conscious rats. Nakamura R; Miyasaka K; Kuyama Y; Kitani K Dig Dis Sci; 1990 Jan; 35(1):55-60. PubMed ID: 2295295 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of octreotide on luminal cholecystokinin-releasing factor, plasma cholecystokinin, and pancreatic secretion in conscious rats. Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A Pancreas; 2002 Apr; 24(3):269-75. PubMed ID: 11893935 [TBL] [Abstract][Full Text] [Related]
10. Effect of intraluminal bile on the feedback regulatory mechanism of pancreatic enzyme secretion in conscious rats. Kataoka K; Kashima K; Kinugasa K; Inada Y; Horii Y; Morinaga O; Yamane Y; Adachi K; Takino T Gastroenterol Jpn; 1985 Jun; 20(3):234-45. PubMed ID: 2412928 [TBL] [Abstract][Full Text] [Related]
11. Feedback regulation by trypsin: evidence for intraluminal CCK-releasing peptide. Miyasaka K; Guan DF; Liddle RA; Green GM Am J Physiol; 1989 Aug; 257(2 Pt 1):G175-81. PubMed ID: 2764106 [TBL] [Abstract][Full Text] [Related]
12. Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Herzig KH; Schön I; Tatemoto K; Ohe Y; Li Y; Fölsch UR; Owyang C Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7927-32. PubMed ID: 8755579 [TBL] [Abstract][Full Text] [Related]
13. Secretory capacity of pancreatic protein during luminal feedback regulation in conscious rats. Okubo K; Masuda M; Miyasaka K; Funakoshi A Jpn J Physiol; 1994; 44(2):205-19. PubMed ID: 7967222 [TBL] [Abstract][Full Text] [Related]
14. Role of secretin and cholecystokinin in oleic acid-stimulated pancreatic secretion in rats. Shiratori K; Watanabe S; Takeuchi T; Shimizu K; Moriyoshi Y Gastroenterol Jpn; 1990 Feb; 25(1):104-11. PubMed ID: 1689684 [TBL] [Abstract][Full Text] [Related]
15. Evidence for autoregulation of cholecystokinin secretion during diversion of bile pancreatic juice in rats. Li Y; Hao Y; Owyang C Gastroenterology; 1995 Jul; 109(1):231-8. PubMed ID: 7797020 [TBL] [Abstract][Full Text] [Related]
16. Necessity of hyperglycemia for effects of endogenous cholecystokinin on insulin and pancreatic exocrine secretion in conscious rats. Shikado F; Miyasaka K; Funakoshi A; Kitani K Jpn J Physiol; 1990; 40(3):383-91. PubMed ID: 2273636 [TBL] [Abstract][Full Text] [Related]
17. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion. Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide. Herzig KH; Louie DS; Owyang C Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637 [TBL] [Abstract][Full Text] [Related]
19. [Potentiating effect of secretin on cholecystokinin-stimulated exocrine pancreatic secretion in rats]. Moriyoshi Y Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2425-33. PubMed ID: 2480464 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of the cholecystokinin antagonist loxiglumide on pancreatic exocrine secretion and pancreatic growth in conscious rats. Taguchi S; Green GM; Nakano I; Hatta Y Int J Pancreatol; 1992 Apr; 11(2):67-73. PubMed ID: 1607730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]